PDB Short entry for 2IWG HEADER IMMUNOGLOBULIN DOMAIN 30-JUN-06 2IWG TITLE COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: RESIDUES 120-326; COMPND 5 SYNONYM: LJ1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: 52 KDA RO PROTEIN; COMPND 9 CHAIN: B, E; COMPND 10 FRAGMENT: RESIDUES 287-465; COMPND 11 SYNONYM: LJ1, SJOEGREN SYNDROME TYPE A ANTIGEN, SS-A, RO, 52 KDA COMPND 12 RIBONUCLEOPROTEIN AUTOANTIGEN RO/SS-A, TRIPARTITE MOTIF PROTEIN 21, COMPND 13 RING FINGER PROTEIN 81; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ZINC, RNA-BINDING, ZINC-FINGER, DNA-BINDING, RIBONUCLEOPROTEIN, KEYWDS 2 IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, SYSTEMIC LUPUS KEYWDS 3 ERYTHEMATOSUS, POLYMORPHISM, GLYCOPROTEIN, METAL-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR L.C.JAMES,A.H.KEEBLE,D.A.RHODES,J.TROWSDALE REVDAT 6 29-JUL-20 2IWG 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 15-NOV-17 2IWG 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 FORMUL LINK SITE ATOM REVDAT 4 24-FEB-09 2IWG 1 VERSN REVDAT 3 24-APR-07 2IWG 1 JRNL REVDAT 2 10-APR-07 2IWG 1 REMARK REVDAT 1 27-MAR-07 2IWG 0 JRNL AUTH L.C.JAMES,A.H.KEEBLE,Z.KHAN,D.A.RHODES,J.TROWSDALE JRNL TITL STRUCTURAL BASIS FOR PRYSPRY-MEDIATED TRIPARTITE MOTIF JRNL TITL 2 (TRIM) PROTEIN FUNCTION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 104 6200 2007 JRNL REFN ISSN 0027-8424 JRNL PMID 17400754 JRNL DOI 10.1073/PNAS.0609174104 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 97.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.1 REMARK 3 NUMBER OF REFLECTIONS : 49869 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.190 REMARK 3 FREE R VALUE TEST SET COUNT : 2533 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 10.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 97.59 REMARK 3 REFLECTION IN BIN (WORKING SET) : 528 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3770 REMARK 3 BIN FREE R VALUE SET COUNT : 24 REMARK 3 BIN FREE R VALUE : 0.4540 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6226 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 192 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 71.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.24200 REMARK 3 B22 (A**2) : -4.24200 REMARK 3 B33 (A**2) : 6.36300 REMARK 3 B12 (A**2) : -2.12100 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.303 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.238 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.204 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.825 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6628 ; 0.035 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3120 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9054 ; 2.588 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7281 ; 3.145 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 772 ; 7.998 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 298 ;36.512 ;24.228 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1034 ;17.918 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;13.845 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1008 ; 0.181 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4984 ; 0.013 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 581 ; 0.008 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2650 ; 0.236 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3043 ; 0.241 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4363 ; 0.323 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 17 ; 0.447 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 241 ; 0.192 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 38 ; 0.255 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 81 ; 0.311 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 28 ; 0.475 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4026 ; 1.830 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6344 ; 2.883 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3003 ; 3.924 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2710 ; 5.453 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 3 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 237 A 443 1 REMARK 3 1 D 237 D 443 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1658 ; 0.05 ; 0.05 REMARK 3 TIGHT THERMAL 1 D (A**2): 1658 ; 0.22 ; 0.50 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : B E REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 B 2 B 184 1 REMARK 3 1 E 2 E 184 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 2 B (A): 1455 ; 0.06 ; 0.05 REMARK 3 TIGHT THERMAL 2 E (A**2): 1455 ; 0.25 ; 0.50 REMARK 3 REMARK 3 NCS GROUP NUMBER : 3 REMARK 3 CHAIN NAMES : A D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1444 A 1451 1 REMARK 3 1 D 1444 D 1451 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 3 A (A): 96 ; 0.04 ; 0.05 REMARK 3 TIGHT POSITIONAL 3 D (A): 96 ; 0.04 ; 0.05 REMARK 3 TIGHT THERMAL 3 A (A**2): 96 ; 0.06 ; 0.50 REMARK 3 TIGHT THERMAL 3 D (A**2): 96 ; 0.06 ; 0.50 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL PLUS MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2IWG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1290029219. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10438 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.86967 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 129.73933 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 97.30450 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 162.17417 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 32.43483 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, E, C, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH D 2032 O HOH D 2040 1.44 REMARK 500 O HOH A 2036 O HOH A 2044 1.56 REMARK 500 O HOH B 2009 O HOH B 2029 1.87 REMARK 500 O HOH E 2039 O HOH E 2040 1.97 REMARK 500 O ASN D 421 O HOH D 2032 2.11 REMARK 500 O HOH E 2004 O HOH E 2005 2.17 REMARK 500 O HOH B 2002 O HOH B 2012 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 294 CD GLU A 294 OE2 0.085 REMARK 500 TYR A 296 CG TYR A 296 CD2 0.082 REMARK 500 TYR A 296 CD1 TYR A 296 CE1 0.097 REMARK 500 TYR A 296 CE1 TYR A 296 CZ 0.092 REMARK 500 TYR A 296 CZ TYR A 296 CE2 0.107 REMARK 500 CYS A 321 CB CYS A 321 SG -0.102 REMARK 500 GLN A 347 CG GLN A 347 CD 0.140 REMARK 500 TYR A 407 CD1 TYR A 407 CE1 0.108 REMARK 500 TYR A 407 CE2 TYR A 407 CD2 0.113 REMARK 500 CYS A 425 CB CYS A 425 SG -0.119 REMARK 500 MET B 3 CG MET B 3 SD 0.195 REMARK 500 GLU B 40 CG GLU B 40 CD 0.101 REMARK 500 LYS B 68 CE LYS B 68 NZ -0.157 REMARK 500 TRP B 98 N TRP B 98 CA -0.125 REMARK 500 TRP B 98 CG TRP B 98 CD1 0.110 REMARK 500 GLY B 108 N GLY B 108 CA 0.096 REMARK 500 VAL B 135 CB VAL B 135 CG1 -0.189 REMARK 500 TYR B 148 CZ TYR B 148 CE2 0.080 REMARK 500 GLU B 152 CG GLU B 152 CD 0.116 REMARK 500 CYS B 153 CB CYS B 153 SG 0.124 REMARK 500 PHE B 162 CE1 PHE B 162 CZ 0.126 REMARK 500 VAL D 282 CB VAL D 282 CG2 0.128 REMARK 500 GLU D 294 CG GLU D 294 CD 0.097 REMARK 500 GLU D 294 CD GLU D 294 OE1 0.068 REMARK 500 GLU D 294 CD GLU D 294 OE2 0.085 REMARK 500 TYR D 296 CG TYR D 296 CD2 0.080 REMARK 500 TYR D 296 CD1 TYR D 296 CE1 0.094 REMARK 500 TYR D 296 CZ TYR D 296 CE2 0.098 REMARK 500 GLN D 347 CG GLN D 347 CD 0.172 REMARK 500 TYR D 391 CD1 TYR D 391 CE1 -0.097 REMARK 500 PHE D 405 CZ PHE D 405 CE2 0.126 REMARK 500 TYR D 407 CG TYR D 407 CD1 0.112 REMARK 500 TYR D 407 CD1 TYR D 407 CE1 0.091 REMARK 500 MET E 3 CG MET E 3 SD 0.169 REMARK 500 GLU E 40 CG GLU E 40 CD 0.105 REMARK 500 VAL E 48 CB VAL E 48 CG2 0.131 REMARK 500 VAL E 65 CB VAL E 65 CG1 0.141 REMARK 500 LYS E 68 CE LYS E 68 NZ -0.166 REMARK 500 VAL E 135 CB VAL E 135 CG1 -0.195 REMARK 500 PHE E 137 CD1 PHE E 137 CE1 0.148 REMARK 500 CYS E 153 CB CYS E 153 SG 0.129 REMARK 500 PHE E 162 CE1 PHE E 162 CZ 0.117 REMARK 500 PHE E 163 CG PHE E 163 CD2 0.129 REMARK 500 PHE E 163 CE1 PHE E 163 CZ 0.148 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 301 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG A 416 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ASP B 11 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 ARG B 27 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG B 41 NE - CZ - NH1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG B 41 NE - CZ - NH2 ANGL. DEV. = -6.1 DEGREES REMARK 500 ASP B 43 CB - CG - OD1 ANGL. DEV. = 7.5 DEGREES REMARK 500 ASP B 43 CB - CG - OD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP B 64 CB - CG - OD2 ANGL. DEV. = 9.2 DEGREES REMARK 500 LYS B 68 CD - CE - NZ ANGL. DEV. = -16.8 DEGREES REMARK 500 ASP B 72 OD1 - CG - OD2 ANGL. DEV. = -17.0 DEGREES REMARK 500 ASP B 72 CB - CG - OD1 ANGL. DEV. = 7.2 DEGREES REMARK 500 ASP B 72 CB - CG - OD2 ANGL. DEV. = 9.9 DEGREES REMARK 500 CYS B 153 CA - CB - SG ANGL. DEV. = 7.4 DEGREES REMARK 500 LEU D 365 CB - CG - CD2 ANGL. DEV. = 11.7 DEGREES REMARK 500 ASP D 399 CB - CG - OD1 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP E 9 CB - CG - OD2 ANGL. DEV. = -7.0 DEGREES REMARK 500 ASP E 11 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG E 41 NE - CZ - NH1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ARG E 41 NE - CZ - NH2 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP E 43 CB - CG - OD1 ANGL. DEV. = 8.8 DEGREES REMARK 500 ASP E 43 CB - CG - OD2 ANGL. DEV. = -7.9 DEGREES REMARK 500 ASP E 64 CB - CG - OD2 ANGL. DEV. = 11.1 DEGREES REMARK 500 ASP E 72 OD1 - CG - OD2 ANGL. DEV. = -17.9 DEGREES REMARK 500 ASP E 72 CB - CG - OD1 ANGL. DEV. = 8.1 DEGREES REMARK 500 ASP E 72 CB - CG - OD2 ANGL. DEV. = 9.6 DEGREES REMARK 500 ARG E 82 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 270 79.80 -117.64 REMARK 500 TYR A 296 -17.46 -49.61 REMARK 500 ASN A 325 148.47 -173.42 REMARK 500 ALA A 327 28.49 -71.96 REMARK 500 ASP A 376 108.69 -55.87 REMARK 500 PRO B 46 53.88 -69.40 REMARK 500 ALA B 70 145.27 -173.07 REMARK 500 LYS B 102 147.96 44.37 REMARK 500 GLN B 103 -17.48 63.10 REMARK 500 ASP B 142 73.02 -110.42 REMARK 500 HIS B 143 8.75 44.85 REMARK 500 TYR B 148 140.43 -172.33 REMARK 500 GLU B 152 66.59 39.35 REMARK 500 ALA B 154 -89.36 76.62 REMARK 500 PHE B 155 106.94 76.11 REMARK 500 ASP D 265 114.77 -34.23 REMARK 500 TYR D 296 -18.75 -48.75 REMARK 500 ASN D 325 148.55 -176.17 REMARK 500 ALA D 327 26.65 -71.87 REMARK 500 PRO E 46 53.34 -64.49 REMARK 500 ALA E 70 140.32 -179.68 REMARK 500 LYS E 102 139.03 42.55 REMARK 500 GLN E 103 -20.75 71.17 REMARK 500 ASP E 142 72.09 -112.88 REMARK 500 HIS E 143 8.83 43.09 REMARK 500 TYR E 148 139.85 -173.65 REMARK 500 ALA E 154 -89.08 76.14 REMARK 500 PHE E 155 110.19 77.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 264 ASP A 265 -128.61 REMARK 500 VAL D 264 ASP D 265 -132.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D2026 DISTANCE = 6.28 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 FUC A 1451 REMARK 610 FUC D 1451 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AJ7 RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5- REMARK 900 (PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION REMARK 900 OF AN ESTEROLYTIC ANTIBODY REMARK 900 RELATED ID: 1AQK RELATED DB: PDB REMARK 900 THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR REMARK 900 TETANUS TOXOID REMARK 900 RELATED ID: 1D5B RELATED DB: PDB REMARK 900 UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1D5I RELATED DB: PDB REMARK 900 UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1D6V RELATED DB: PDB REMARK 900 CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE REMARK 900 ANTIBODY MATURATION REMARK 900 RELATED ID: 1DN2 RELATED DB: PDB REMARK 900 FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE REMARK 900 PEPTIDE DCAWHLGELVWCT-NH2 REMARK 900 RELATED ID: 1E4K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA REMARK 900 RECEPTOR III COMPLEX REMARK 900 RELATED ID: 1FC1 RELATED DB: PDB REMARK 900 FC FRAGMENT (IGG1 CLASS) REMARK 900 RELATED ID: 1FC2 RELATED DB: PDB REMARK 900 RELATED ID: 1FCC RELATED DB: PDB REMARK 900 RELATED ID: 1H3T RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3U RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3V RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3W RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN IGG1 FC- FRAGMENT,HIGH SALTCONDITION REMARK 900 RELATED ID: 1HZH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROADAND POTENT REMARK 900 ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: ATEMPLATE FOR HIV VACCINE REMARK 900 DESIGN REMARK 900 RELATED ID: 1I7Z RELATED DB: PDB REMARK 900 ANTIBODY GNC92H2 BOUND TO LIGAND REMARK 900 RELATED ID: 1IIS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FCG RECEPTOR IN COMPLEX WITHAN FC REMARK 900 FRAGMENT OF IGG1 ( ORTHORHOMBIC) REMARK 900 RELATED ID: 1IIX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FCG RECEPTOR IN COMPLEX WITHAN FC REMARK 900 FRAGMENT OF IGG1 ( HEXAGONAL) REMARK 900 RELATED ID: 1L6X RELATED DB: PDB REMARK 900 FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OFTHE B- REMARK 900 DOMAIN FROM PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1N7M RELATED DB: PDB REMARK 900 GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN REMARK 900 RELATED ID: 1OQX RELATED DB: PDB REMARK 900 G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSIONOF REMARK 900 PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1T83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR INCOMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC) REMARK 900 RELATED ID: 2RCS RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB - AFFINITY MATURATION OF AN REMARK 900 ESTEROLYTIC ANTIBODY DBREF 2IWG A 237 443 UNP P01857 IGHG1_HUMAN 120 326 DBREF 2IWG B 2 3 PDB 2IWG 2IWG 2 3 DBREF 2IWG B 4 182 UNP P19474 RO52_HUMAN 287 465 DBREF 2IWG D 237 443 UNP P01857 IGHG1_HUMAN 120 326 DBREF 2IWG E 2 3 PDB 2IWG 2IWG 2 3 DBREF 2IWG E 4 182 UNP P19474 RO52_HUMAN 287 465 SEQRES 1 A 207 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 2 A 207 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 3 A 207 VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE SEQRES 4 A 207 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 5 A 207 THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG SEQRES 6 A 207 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 7 A 207 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA SEQRES 8 A 207 LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 9 A 207 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SEQRES 10 A 207 SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU THR SEQRES 11 A 207 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 12 A 207 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 13 A 207 THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE SEQRES 14 A 207 LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 15 A 207 GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 16 A 207 LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SEQRES 1 B 181 HIS MET VAL HIS ILE THR LEU ASP PRO ASP THR ALA ASN SEQRES 2 B 181 PRO TRP LEU ILE LEU SER GLU ASP ARG ARG GLN VAL ARG SEQRES 3 B 181 LEU GLY ASP THR GLN GLN SER ILE PRO GLY ASN GLU GLU SEQRES 4 B 181 ARG PHE ASP SER TYR PRO MET VAL LEU GLY ALA GLN HIS SEQRES 5 B 181 PHE HIS SER GLY LYS HIS TYR TRP GLU VAL ASP VAL THR SEQRES 6 B 181 GLY LYS GLU ALA TRP ASP LEU GLY VAL CYS ARG ASP SER SEQRES 7 B 181 VAL ARG ARG LYS GLY HIS PHE LEU LEU SER SER LYS SER SEQRES 8 B 181 GLY PHE TRP THR ILE TRP LEU TRP ASN LYS GLN LYS TYR SEQRES 9 B 181 GLU ALA GLY THR TYR PRO GLN THR PRO LEU HIS LEU GLN SEQRES 10 B 181 VAL PRO PRO CYS GLN VAL GLY ILE PHE LEU ASP TYR GLU SEQRES 11 B 181 ALA GLY MET VAL SER PHE TYR ASN ILE THR ASP HIS GLY SEQRES 12 B 181 SER LEU ILE TYR SER PHE SER GLU CYS ALA PHE THR GLY SEQRES 13 B 181 PRO LEU ARG PRO PHE PHE SER PRO GLY PHE ASN ASP GLY SEQRES 14 B 181 GLY LYS ASN THR ALA PRO LEU THR LEU CYS PRO LEU SEQRES 1 D 207 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 2 D 207 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 3 D 207 VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE SEQRES 4 D 207 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 5 D 207 THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG SEQRES 6 D 207 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 7 D 207 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA SEQRES 8 D 207 LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 9 D 207 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SEQRES 10 D 207 SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU THR SEQRES 11 D 207 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 12 D 207 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 13 D 207 THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE SEQRES 14 D 207 LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 15 D 207 GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 16 D 207 LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SEQRES 1 E 181 HIS MET VAL HIS ILE THR LEU ASP PRO ASP THR ALA ASN SEQRES 2 E 181 PRO TRP LEU ILE LEU SER GLU ASP ARG ARG GLN VAL ARG SEQRES 3 E 181 LEU GLY ASP THR GLN GLN SER ILE PRO GLY ASN GLU GLU SEQRES 4 E 181 ARG PHE ASP SER TYR PRO MET VAL LEU GLY ALA GLN HIS SEQRES 5 E 181 PHE HIS SER GLY LYS HIS TYR TRP GLU VAL ASP VAL THR SEQRES 6 E 181 GLY LYS GLU ALA TRP ASP LEU GLY VAL CYS ARG ASP SER SEQRES 7 E 181 VAL ARG ARG LYS GLY HIS PHE LEU LEU SER SER LYS SER SEQRES 8 E 181 GLY PHE TRP THR ILE TRP LEU TRP ASN LYS GLN LYS TYR SEQRES 9 E 181 GLU ALA GLY THR TYR PRO GLN THR PRO LEU HIS LEU GLN SEQRES 10 E 181 VAL PRO PRO CYS GLN VAL GLY ILE PHE LEU ASP TYR GLU SEQRES 11 E 181 ALA GLY MET VAL SER PHE TYR ASN ILE THR ASP HIS GLY SEQRES 12 E 181 SER LEU ILE TYR SER PHE SER GLU CYS ALA PHE THR GLY SEQRES 13 E 181 PRO LEU ARG PRO PHE PHE SER PRO GLY PHE ASN ASP GLY SEQRES 14 E 181 GLY LYS ASN THR ALA PRO LEU THR LEU CYS PRO LEU MODRES 2IWG ASN A 297 ASN GLYCOSYLATION SITE MODRES 2IWG ASN D 297 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET GAL C 6 11 HET MAN C 7 11 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HET NAG F 5 14 HET GAL F 6 11 HET MAN F 7 11 HET FUC A1451 10 HET FUC D1451 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE FORMUL 5 NAG 6(C8 H15 N O6) FORMUL 5 BMA 2(C6 H12 O6) FORMUL 5 MAN 4(C6 H12 O6) FORMUL 5 GAL 2(C6 H12 O6) FORMUL 7 FUC 2(C6 H12 O5) FORMUL 9 HOH *172(H2 O) HELIX 1 1 LYS A 246 LEU A 251 5 6 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 SER A 354 LYS A 360 5 7 HELIX 4 4 LYS A 414 GLY A 420 1 7 HELIX 5 5 LEU A 432 ASN A 434 5 3 HELIX 6 6 LYS D 246 LEU D 251 5 6 HELIX 7 7 LEU D 309 ASN D 315 1 7 HELIX 8 8 SER D 354 LYS D 360 5 7 HELIX 9 9 LYS D 414 GLY D 420 1 7 HELIX 10 10 LEU D 432 ASN D 434 5 3 HELIX 11 11 ASN E 168 LYS E 172 5 5 SHEET 1 AA 4 SER A 239 PHE A 243 0 SHEET 2 AA 4 GLU A 258 SER A 267 -1 O THR A 260 N PHE A 243 SHEET 3 AA 4 THR A 299 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AA 4 LYS A 288 THR A 289 -1 O LYS A 288 N VAL A 305 SHEET 1 AB 4 SER A 239 PHE A 243 0 SHEET 2 AB 4 GLU A 258 SER A 267 -1 O THR A 260 N PHE A 243 SHEET 3 AB 4 THR A 299 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AB 4 GLU A 293 GLN A 295 -1 O GLU A 293 N ARG A 301 SHEET 1 AC 4 GLU A 283 VAL A 284 0 SHEET 2 AC 4 LYS A 274 VAL A 279 -1 O TRP A 277 N VAL A 284 SHEET 3 AC 4 TYR A 319 SER A 324 -1 O LYS A 320 N TYR A 278 SHEET 4 AC 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 AD 4 GLN A 347 LEU A 351 0 SHEET 2 AD 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AD 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AD 4 TYR A 391 THR A 393 -1 O LYS A 392 N LYS A 409 SHEET 1 AE 4 GLN A 347 LEU A 351 0 SHEET 2 AE 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AE 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AE 4 VAL A 397 LEU A 398 -1 O VAL A 397 N PHE A 405 SHEET 1 AF 4 GLN A 386 PRO A 387 0 SHEET 2 AF 4 ALA A 378 SER A 383 -1 O SER A 383 N GLN A 386 SHEET 3 AF 4 PHE A 423 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 4 AF 4 TYR A 436 LEU A 441 -1 O THR A 437 N VAL A 427 SHEET 1 BA 7 LEU B 17 LEU B 19 0 SHEET 2 BA 7 GLN B 25 LEU B 28 -1 O ARG B 27 N ILE B 18 SHEET 3 BA 7 LEU B 177 LEU B 179 -1 O LEU B 177 N VAL B 26 SHEET 4 BA 7 LYS B 58 ASP B 64 -1 O ASP B 64 N THR B 178 SHEET 5 BA 7 GLN B 123 ASP B 129 -1 O VAL B 124 N VAL B 63 SHEET 6 BA 7 MET B 134 ASN B 139 -1 O MET B 134 N ASP B 129 SHEET 7 BA 7 LEU B 146 PHE B 150 -1 N ILE B 147 O PHE B 137 SHEET 1 BB 6 VAL B 48 LEU B 49 0 SHEET 2 BB 6 LEU B 159 SER B 164 -1 O PHE B 163 N VAL B 48 SHEET 3 BB 6 TRP B 71 ARG B 77 -1 O ASP B 72 N SER B 164 SHEET 4 BB 6 PHE B 94 TRP B 100 -1 O TRP B 95 N VAL B 75 SHEET 5 BB 6 LYS B 104 ALA B 107 -1 O LYS B 104 N TRP B 100 SHEET 6 BB 6 THR B 113 LEU B 115 -1 O THR B 113 N ALA B 107 SHEET 1 DA 4 SER D 239 PHE D 243 0 SHEET 2 DA 4 GLU D 258 SER D 267 -1 O THR D 260 N PHE D 243 SHEET 3 DA 4 THR D 299 THR D 307 -1 O TYR D 300 N VAL D 266 SHEET 4 DA 4 LYS D 288 THR D 289 -1 O LYS D 288 N VAL D 305 SHEET 1 DB 4 SER D 239 PHE D 243 0 SHEET 2 DB 4 GLU D 258 SER D 267 -1 O THR D 260 N PHE D 243 SHEET 3 DB 4 THR D 299 THR D 307 -1 O TYR D 300 N VAL D 266 SHEET 4 DB 4 GLU D 293 GLN D 295 -1 O GLU D 293 N ARG D 301 SHEET 1 DC 4 GLU D 283 VAL D 284 0 SHEET 2 DC 4 LYS D 274 VAL D 279 -1 O TRP D 277 N VAL D 284 SHEET 3 DC 4 TYR D 319 SER D 324 -1 O LYS D 320 N TYR D 278 SHEET 4 DC 4 ILE D 332 ILE D 336 -1 O ILE D 332 N VAL D 323 SHEET 1 DD 7 GLN D 347 LEU D 351 0 SHEET 2 DD 7 GLN D 362 PHE D 372 -1 O THR D 366 N LEU D 351 SHEET 3 DD 7 PHE D 404 ASP D 413 -1 O PHE D 404 N PHE D 372 SHEET 4 DD 7 TYR D 391 THR D 393 -1 O LYS D 392 N LYS D 409 SHEET 5 DD 7 PHE D 404 ASP D 413 -1 O LYS D 409 N LYS D 392 SHEET 6 DD 7 VAL D 397 LEU D 398 -1 O VAL D 397 N PHE D 405 SHEET 7 DD 7 PHE D 404 ASP D 413 -1 O PHE D 405 N VAL D 397 SHEET 1 DE 4 GLN D 386 GLU D 388 0 SHEET 2 DE 4 ALA D 378 SER D 383 -1 O TRP D 381 N GLU D 388 SHEET 3 DE 4 PHE D 423 MET D 428 -1 O SER D 424 N GLU D 382 SHEET 4 DE 4 TYR D 436 LEU D 441 -1 O THR D 437 N VAL D 427 SHEET 1 EA 7 LEU E 17 LEU E 19 0 SHEET 2 EA 7 GLN E 25 LEU E 28 -1 O ARG E 27 N ILE E 18 SHEET 3 EA 7 LEU E 177 LEU E 179 -1 O LEU E 177 N VAL E 26 SHEET 4 EA 7 LYS E 58 ASP E 64 -1 O ASP E 64 N THR E 178 SHEET 5 EA 7 GLN E 123 ASP E 129 -1 O VAL E 124 N VAL E 63 SHEET 6 EA 7 MET E 134 ASN E 139 -1 O MET E 134 N ASP E 129 SHEET 7 EA 7 LEU E 146 PHE E 150 -1 N ILE E 147 O PHE E 137 SHEET 1 EB 6 VAL E 48 LEU E 49 0 SHEET 2 EB 6 LEU E 159 SER E 164 -1 O PHE E 163 N VAL E 48 SHEET 3 EB 6 TRP E 71 ARG E 77 -1 O ASP E 72 N SER E 164 SHEET 4 EB 6 PHE E 94 TRP E 100 -1 O TRP E 95 N VAL E 75 SHEET 5 EB 6 LYS E 104 ALA E 107 -1 O LYS E 104 N TRP E 100 SHEET 6 EB 6 THR E 113 PRO E 114 -1 O THR E 113 N ALA E 107 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.09 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.16 SSBOND 3 CYS D 261 CYS D 321 1555 1555 2.08 SSBOND 4 CYS D 367 CYS D 425 1555 1555 2.11 LINK ND2 ASN A 297 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN D 297 C1 NAG F 1 1555 1555 1.46 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.43 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.48 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.42 LINK O3 BMA C 3 C1 MAN C 7 1555 1555 1.48 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.48 LINK O4 NAG C 5 C1 GAL C 6 1555 1555 1.42 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.44 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.47 LINK O6 BMA F 3 C1 MAN F 4 1555 1555 1.43 LINK O3 BMA F 3 C1 MAN F 7 1555 1555 1.48 LINK O2 MAN F 4 C1 NAG F 5 1555 1555 1.46 LINK O4 NAG F 5 C1 GAL F 6 1555 1555 1.41 CISPEP 1 TYR A 373 PRO A 374 0 -2.19 CISPEP 2 TYR B 110 PRO B 111 0 -8.09 CISPEP 3 TYR D 373 PRO D 374 0 -1.31 CISPEP 4 TYR E 110 PRO E 111 0 -5.12 CRYST1 112.490 112.490 194.609 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008890 0.005132 0.000000 0.00000 SCALE2 0.000000 0.010265 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005139 0.00000